Pfizer (PFE) shares fell 2.6% in Thursday trading after the company reaffirmed its fiscal 2026 guidance in a regulatory filing.
The company continues to expect fiscal 2026 adjusted earnings of $2.80 to $3.00 per diluted share and revenue range of $59.5 billion to $62.5 billion, according to the filing with the US Securities and Exchange Commission.
Analysts surveyed by FactSet expect $2.96 and $61.74 billion, respectively.
Price: 25.25, Change: -0.67, Percent Change: -2.58
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.